Related Experiment Videos
Cyclobenzaprine and back pain: a meta-analysis.
R Browning1, J L Jackson, P G O'Malley
1Department of Medicine, National Naval Medical Center, Bethesda, MD, USA. browning_robert@hotmail.com
Archives of Internal Medicine
|July 24, 2001
Summary
Cyclobenzaprine offers modest relief for back pain compared to placebo, with benefits most pronounced in the initial days of treatment. However, increased adverse effects like drowsiness are associated with its use.
Area of Science:
- Pharmacology
- Pain Management
- Clinical Trials
Background:
- Back pain is a prevalent condition frequently managed with cyclobenzaprine hydrochloride.
- The study addresses the need for a systematic review on cyclobenzaprine's efficacy in back pain treatment.
Purpose of the Study:
- To systematically review the effectiveness of cyclobenzaprine in treating back pain.
- To evaluate cyclobenzaprine's impact on various back pain domains and overall symptom improvement.
Main Methods:
- Conducted a comprehensive literature search across multiple databases for randomized, placebo-controlled trials.
- Included studies focusing on adult back pain patients treated with cyclobenzaprine.
- Assessed study quality using Jadad methods and employed a random-effects model for outcome synthesis.
Main Results:
- Patients on cyclobenzaprine were nearly 5 times more likely to report symptom improvement by day 14 compared to placebo.
- A modest effect size (0.38-0.58) was observed across five key back pain outcomes.
- Efficacy was greatest in the first few days, diminishing after the first week; drowsiness was a common adverse effect.
Conclusions:
- Cyclobenzaprine demonstrates greater effectiveness than placebo for back pain, albeit with modest benefits and increased side effects.
- The early onset of action suggests shorter treatment durations may be optimal.
- Further research is recommended to compare cyclobenzaprine with other analgesics like acetaminophen and NSAIDs.